giulia.piaggio

About Giulia Piaggio

This author has not yet filled in any details.
So far Giulia Piaggio has created 75 blog entries.

The challenge of the cosmetics industry: discovering compounds that block pollutants in contact with the skin.

2020-11-18T11:15:23+00:00

Scientific research shows that polluting particles are extremely fine and highly dangerous. Our test allows to quantify the percentage of particulate passes through the skin model to determine the protective factor of the cosmetic compound. We call it "antipollution test": it is fast, innovative and effective. Air pollution can cause serious health problems, especially [...]

The challenge of the cosmetics industry: discovering compounds that block pollutants in contact with the skin.2020-11-18T11:15:23+00:00

Reducing the time and cost of screening for new compounds and limiting the number of animals used in in-vivo tests is the future of drug discovery.

2020-10-16T09:48:53+00:00

Cristina Degrassi, CEO of MTTLab, tells us about her experience with React4life which led to the publication of the paper on Altex: "3D fluid-dynamic ovarian cancer model resembling systemic drug administration for efficacy assay". The ability to control drugs quickly and efficiently with a more accurate preclinical tumor model is of great importance in [...]

Reducing the time and cost of screening for new compounds and limiting the number of animals used in in-vivo tests is the future of drug discovery.2020-10-16T09:48:53+00:00

3D fluid-dynamic ovarian cancer model resembling systemic drug administration for efficacy assay

2020-09-03T08:40:31+00:00

In this recent scientific result, our team demonstrates that the in vivo-like dynamic environment provided by the MIVO® device allows for better modeling of the 3D tumor environment and predicting drug efficacy in vivo compared to a static in vitro model. Scheme of the in vitro 3D human cancer culture within MIVO® chamber under [...]

3D fluid-dynamic ovarian cancer model resembling systemic drug administration for efficacy assay2020-09-03T08:40:31+00:00

MIVO® and intestinal permeability, a perfect combination to study the absorption mechanism and the biological effects of drugs and food compounds

2020-08-27T13:22:02+00:00

MIVO®  technology has made possible the implementation of a fluidic 3D in vitro model of the intestinal barrier. In this article it is demonstrated that MIVO®, combined with a 3D intestinal epithelium model, allows to emulate the intestinal environment in vitro, as a reliable platform for the study of the passage of molecules, discriminating [...]

MIVO® and intestinal permeability, a perfect combination to study the absorption mechanism and the biological effects of drugs and food compounds2020-08-27T13:22:02+00:00

Livia, React4lifer to learn the techniques of an R&D laboratory

2020-08-06T09:52:54+00:00

Polyglot, bioengineer, pianist and a few weeks ago React4lifer! We introduce Livia who is doing a stage in our R&D district in Vimodrone Livia, tell us about yourself I am an Italian girl, born and raised in Brussels and I am currently studying Biomedical Engineering at Imperial College London. Overall, I am a creative [...]

Livia, React4lifer to learn the techniques of an R&D laboratory2020-08-06T09:52:54+00:00

3D Human Cancer Models with MIVO and Culturing 3D Tissues: we talk about it today at the Drug Discovery summit

2020-07-30T08:03:05+00:00

"A Biology-Driven Multi-Chamber Device For Culturing 3D Tissues And Performing Reliable Absorption Assays" and "3D Human Cancer Models Within The MIVO- Multi In Vitro Organ Fluidic Device For Improving The Outcome Of In Vitro Drug Testing" are the titles of our poster on Oxofrod Global today. We are proud to be here to present [...]

3D Human Cancer Models with MIVO and Culturing 3D Tissues: we talk about it today at the Drug Discovery summit2020-07-30T08:03:05+00:00

Covid19 and heart: an advanced in vitro research on infection mechanism

2020-07-16T13:32:06+00:00

Monzino and Spallanzani, with the biotech React4life, join forces to study new therapies to protect the heart from the virus. Regione Lombardia finances the Cardio-Cov research project. To understand the mechanisms on the heart connected to COVID-19, Centro Cardiologico Monzino, with the collaboration of the National Institute of Infectious Diseases (INMI) "Lazzaro Spallanzani" in [...]

Covid19 and heart: an advanced in vitro research on infection mechanism2020-07-16T13:32:06+00:00

Our Organ On-Chip device at EUROoCs2020

2020-07-06T11:31:13+00:00

At the European Organ-On-Chip Society meeting we will present: “3D Human Tissues Within The MIVO-Multi In Vitro Organ Fluidic Device for Improving The Outcome Of In Vitro Drug Testing Assays” to demonstrate how the MIVO® platform combined with 3D human tissues can they represent a novel, highly reliable and easy to use in vitro [...]

Our Organ On-Chip device at EUROoCs20202020-07-06T11:31:13+00:00

React4life among the top 23 EIC-funded SMEs to meet ROCHE

2020-07-03T09:23:50+00:00

For the third straight year, the European Innovation Council has organized the EIC Corporate Days, gathering innovative European SMEs and large corporates to take full advantage of partnering opportunities. This year, the pharmaceutical giant ROCHE was also invited to meet EIC-funded SMEs and participate in the EIC Corporate Day initiative. From 22 till 25 June 2020, [...]

React4life among the top 23 EIC-funded SMEs to meet ROCHE2020-07-03T09:23:50+00:00

Webinar “Is the future goal reduce animal tests on research?

2020-06-05T12:06:40+00:00

What we really know about drug tests: advantages and disadvantages of 3R methods and animal tests.  The principles of 3R (replacement, reduction and refinement) were developed over 50 years ago to conduct research on more human animals. Biomedical research requires continuous updating on solid experimental models and in this scenario 3R-based approaches can become [...]

Webinar “Is the future goal reduce animal tests on research?2020-06-05T12:06:40+00:00